New HER2-negative breast cancer subtype responsive to anti-HER2 therapy identified.
MacNeil IA, Burns DJ, Rich BE, Soltani SM, Kharbush S, Osterhaus NG, Sullivan BF, Hawkins DM, Pietruska JR, Laing LG.
MacNeil IA, et al. Among authors: hawkins dm.
J Cancer Res Clin Oncol. 2020 Mar;146(3):605-619. doi: 10.1007/s00432-020-03144-7. Epub 2020 Feb 8.
J Cancer Res Clin Oncol. 2020.
PMID: 32036454
Free PMC article.